About
Nexyra Advanced Research is a deep tech biotechnology startup based in Madrid, Spain, developing AI-powered multi-omics analysis platforms to accelerate scientific discovery and translational research in biomedical and biotechnology.
Its mission is focused on transforming complex omics data (metabolomics, transcriptomics, genomics, etc.) into functional insights, clinical biomarkers, and actionable therapeutic strategies.
Nexyra offers a broad portfolio of AI-powered, customized omics data analysis and services that can be grouped into several key areas.
It integrates over 1.4 million transcriptome variants and over 4.4 million gene-disease associations from databases such as DisGeNET and Orphanet.
It utilizes approximately 38,100 disease-phenotype relationships derived from ontologies such as HPO, DOID, or biomarker databases for rare diseases, facilitating clinical interpretation.
It connects more than 28 million multi-omics relationships between diseases, genes, and metabolic profiles, and also incorporates approximately 14,000 interactions between drugs, toxic compounds, and clinical phenotypes, enabling analyses of toxicity and pharmacological effects.
It employs automatic ortholog mapping between humans and mice, enabling the study of animal data and its translation into human contexts.
Big Data & Advanced computing
Big Data
Artificial Intelligence & Machine Learning
Deep learning, reinforcement learning, generative AI, foundation modelsDigital twins